Sjogren Syndrome With Other Organ Involvement Clinical Trial
Official title:
Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in Sjogren's Syndrome
This 12-week randomized, open-label study evaluates the efficacy and safety of Tacrolimus combined with Glucocorticoid for Sjogren's syndrome patients with severe thrombocytopenia.
This study evaluates the efficacy and safety of Tacrolimus combined with Glucocorticoid for the treatment of severe thrombocytopenia in Sjogren's syndrome patients. ;